Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Biogen Inc. buy William Blair

Start price
€229.60
26.10.23 / 50%
Target price
-
26.10.24
Performance (%)
-14.94%
Price
€195.30
26.04.24
Summary
This prediction is currently active. The price of Biogen Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -14.94%. This prediction currently runs until 26.10.24. The prediction end date can be changed by William_Blair at any time. William_Blair has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Biogen Inc. 7.014% 7.014%
iShares Core DAX® 2.594% -1.158%
iShares Nasdaq 100 3.553% -1.727%
iShares Nikkei 225® 0.687% -8.354%
iShares S&P 500 2.209% -0.942%

Comments by William_Blair for this prediction

In the thread Biogen Inc. diskutieren

Biogen Inc. (NASDAQ: BIIB) had its "outperform" rating re-affirmed by analysts at William Blair.
Ratings data for BIIB provided by MarketBeat

Stopped prediction by William_Blair for Biogen Inc.

buy
Biogen Inc.

Start price
Target price
Perf. (%)
€200.90
01.04.24
-
01.04.25
-2.79%
26.04.24

buy
Biogen Inc.

Start price
Target price
Perf. (%)
€231.40
10.01.24
-
10.01.25
-15.60%
26.04.24

buy
Biogen Inc.

Start price
Target price
Perf. (%)
€209.60
09.11.23
-
09.11.24
-6.82%
26.04.24